Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study

This study showed that the presence of some axSpA disease manifestations were associated with prolonged biologic drug survival. Psoriasis and peripheral musculoskeletal manifestations were the most significant predictors of treatment retention. Future research will be needed to further refine treatment strategies according to specific disease manifestations.

Authors

Institutions

Publication Details

Journal
Rheumatology Advances in Practice
Published
2024-12-18
DOI
https://doi.org/10.1093/rap/rkaf004
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study

Lihi Eder, Sibel Zehra Aydın, Tina Chim, Robert D. Inman et al.
Rheumatology Advances in Practice
Spondyloarthritis Studies and Treatments
article

Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study

Lihi Eder, Sibel Zehra Aydın, Tina Chim, Robert D. Inman, Bindu Nair, Zeynep Baskurt, Dax G. Rumsey, Dafna D. Gladman, Louis Bessette, Sherry Rohekar, Michael Starr, Nigil Haroon, R. Hurtubise, Shirley M. L. Tse, Proton Rahman, Jonathan Chan, Olga Ziouzina, Alexander Tsoukas, Paul R. Fortin, Michel Zummer, Nicolas Richard, Vinod Chandran, Tristan Boyd, Dianne Mosher, Carter Thorne
article en

Abstract

This study showed that the presence of some axSpA disease manifestations were associated with prolonged biologic drug survival. Psoriasis and peripheral musculoskeletal manifestations were the most significant predictors of treatment retention. Future research will be needed to further refine treatment strategies according to specific disease manifestations.

Rheumatology Advances in PracticeVol. 9(1)
Western University (CA), University Health Network (CA), Hôpital Maisonneuve-Rosemont (CA), Université de Montréal (CA)
Good health and well-being
Openalex Percentile: Top 56%
Spondyloarthritis Studies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.